Over the next few years, the patents for many therapeutic biologics will expire, allowing drug manufacturers to request US Food and Drug Administration (FDA) approval for biosimilars, medical… Read more

Informed consent to participation in a clinical trial involves substantially more than obtaining signatures from subjects on a written form. It includes providing to potential participants enough information… Read more

A common trend in the drug development industry is to utilize data and innovation to safely begin participant involvement earlier and earlier in clinical trials.  As innovation continues… Read more